Skip to content

Insider · CIK 0001704234

Declan Doogan

director

Files at TENX (TENAX THERAPEUTICS, INC.). First filing Sep 17, 2026, latest Sep 17, 2026.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$102k bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

TENX: TENAX THERAPEUTICS, INC.

TENXOct 9, 2026 · close 1.87

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
50Moderate
TENXbuy 4
TENAX THERAPEUTICS, INC.
$102k
53,000 shares
+2331%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 16, 2026TENX
TENAX THERAPEUTICS, INC.
POpen-market purchase
Common Stock
+53,000$1.92$102k55,27425 d ago
Jan 9, 2026TENX
TENAX THERAPEUTICS, INC.
AGrant or award
Stock Option (right to buy)derivative
+30,000$0.00$030,000Jan 13, 2026
Jul 1, 2025TENX
TENAX THERAPEUTICS, INC.
AGrant or award
Stock Option (right to buy)derivative
+80,000$0.00$080,000Jul 3, 2025
Dec 10, 2024TENX
TENAX THERAPEUTICS, INC.
AGrant or award
Stock Option (right to buy)derivative
+100,000$0.00$0100,000Dec 12, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Declan Doogan: insider trades and track record | InsiderTell